Medybiz Pharma Private Limited, a active private limited company, was established on 23 November 2009 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24117KA2009PTC051603. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹15.48 Cr and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 102 professional, Its leadership includes Ramasubramani Ganesan (Director), Vaibhav Tewari (Director). Past directors included Deepak Krishna Gopal Maheshwari, Sanjeev Bajpai, Kewal Kundanlal Handa. It holds ₹54.70 Cr open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.69/B, 1St Cross, 1St Stage Domlur Layout, Bangalore, Karnataka, 560071.
U24117KA2009PTC051603
051603
23 November 2009
₹15.48 Cr
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Medybiz Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramasubramani Ganesan | Director | 19 Sep 2024 | Current |
| Vaibhav Tewari | Director | 29 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Dec 2010 | Past |
| Pramod Abcsdd | Managing Director | 11 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2013 | Past |
| Pramod Abcsdd | Director | 24 Feb 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medybiz Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.3% increase. The company also saw a substantial fall in profitability, with a 36.84% decrease in profit. The company's net worth Soared by an impressive increase of 52.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Medybiz Pharma had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹547,000,000.00
₹20,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Apr 2023 | The Hongkong And Shanghai Banking Corporation Limited | ₹7.00 M | Open |
| 10 Apr 2023 | The Hongkong And Shanghai Banking Corporation Limited | ₹41.00 Cr | Open |
| 10 Apr 2023 | The Hongkong And Shanghai Banking Corporation Limited | ₹13.00 Cr | Open |
| 04 Feb 2020 | Axis Bank Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Medybiz Pharma has a workforce of 102 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medybiz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medybiz Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 41.00 Cr registered on 10 Apr 2023 with Charge ID 100706388 was modified on 31 Jul 2025. was recorded as a recent event.
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 13.00 Cr registered on 10 Apr 2023 with Charge ID 100706385 was modified on 31 Jul 2025. was recorded as a recent event.
The activity Medybiz Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Ramasubramani Ganesan was appointed as a Director was appointed as a Director on 19 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
Medybiz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
The activity Aditi Pratik Shah was appointed as a Company Secretary was appointed as a Company Secretary on 09 Nov 2023 & has been associated with this company since 2 years 24 days . was completed.
The acquisition will help Portea penetrate deeper into categories such as respiratory care, geriatric care and orthopedics.
The CIN of Medybiz Pharma Private Limited is U24117KA2009PTC051603.
Medybiz Pharma Private Limited is headquartered at No.69/B, 1St Cross, 1St Stage Domlur Layout, Bangalore, Karnataka, 560071.
Medybiz Pharma Private Limited was incorporated on 23 November 2009.
The current directors of Medybiz Pharma Private Limited are
The primary industry of Medybiz Pharma Private Limited is Hospital And Medical Care.
Medybiz Pharma Private Limited is unlisted.
The authorized capital of Medybiz Pharma Private Limited is ₹15.48 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Medybiz Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX